Canada markets open in 1 hour 50 minutes

IVERIC bio, Inc. (ISEE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.81+0.68 (+5.61%)
At close: 04:00PM EDT
12.81 0.00 (0.00%)
After hours: 04:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.35B
Enterprise Value 1.04B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.62
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 332.47%
S&P500 52-Week Change 3-6.48%
52 Week High 319.34
52 Week Low 38.37
50-Day Moving Average 310.69
200-Day Moving Average 314.02

Share Statistics

Avg Vol (3 month) 32.11M
Avg Vol (10 day) 31.98M
Shares Outstanding 5118.08M
Implied Shares Outstanding 6N/A
Float 897.05M
% Held by Insiders 10.59%
% Held by Institutions 1110.15%
Shares Short (Jul 14, 2022) 47.45M
Short Ratio (Jul 14, 2022) 43.31
Short % of Float (Jul 14, 2022) 46.40%
Short % of Shares Outstanding (Jul 14, 2022) 46.37%
Shares Short (prior month Jun 14, 2022) 48.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.59%
Return on Equity (ttm)-65.38%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-85.07M
EBITDA -142.04M
Net Income Avi to Common (ttm)-141.38M
Diluted EPS (ttm)-1.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)311.96M
Total Cash Per Share (mrq)2.64
Total Debt (mrq)2.06M
Total Debt/Equity (mrq)0.70
Current Ratio (mrq)11.98
Book Value Per Share (mrq)2.51

Cash Flow Statement

Operating Cash Flow (ttm)-122.07M
Levered Free Cash Flow (ttm)-71.43M